Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 21,651 | 19,392 | 19,192 | 15,639 | 13,370 |
| Operating Income | -21,651 | -19,392 | -19,192 | -15,639 | -13,370 |
| Other Income | 2,357 | 2,052 | 1,488 | 640 | 105 |
| Pre-tax Income | -19,294 | -17,340 | -17,704 | -14,999 | -13,265 |
| Net Income Continuous | -19,294 | -17,340 | -17,704 | -14,999 | -13,265 |
| Net Income | $-19,294 | $-17,340 | $-17,704 | $-14,999 | $-13,265 |
| EPS Basic Total Ops | -0.35 | -0.31 | -0.32 | -0.27 | -0.24 |
| EPS Basic Continuous Ops | -0.35 | -0.31 | -0.32 | -0.27 | -0.24 |
| EPS Diluted Total Ops | -0.35 | -0.31 | -0.32 | -0.27 | -0.24 |
| EPS Diluted Continuous Ops | -0.35 | -0.31 | -0.32 | -0.27 | -0.24 |
| EBITDA(a) | $-22,664 | $-20,167 | $-19,542 | $-15,605 | $-13,269 |